‌

US Patent 11913952 Methods for detecting peptide/MHC/TCR binding

Patent 11913952 was granted and assigned to PROGNOSYS BIOSCIENCES, INC. on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
1
Current Assignee
‌
PROGNOSYS BIOSCIENCES, INC.
1
Date Filed
November 22, 2021
1
Date of Patent
February 27, 2024
1
Patent Applicant
‌
PROGNOSYS BIOSCIENCES, INC.
1
Patent Application Number
17532728
1
Patent Citations
‌
US Patent 7378242 DNA sequence detection by limited primer extension
1
‌
US Patent 7393665 Methods and compositions for tagging and identifying polynucleotides
1
‌
US Patent 7407757 Genetic analysis by sequence-specific sorting
1
‌
US Patent 7537897 Molecular counting
1
‌
US Patent 7544473 Nucleic acid analysis using sequence tokens
1
‌
US Patent 7579153 Isothermal DNA amplification
1
‌
US Patent 7635566 Methods and compositions for isolating nucleic acid sequence variants
1
‌
US Patent 7666612 Methods for protein labeling based on acyl carrier protein
1
‌
US Patent 7674752 Functional protein arrays
1
‌
US Patent 7776547 Cellular analysis using Raman surface scanning
1
•••
Patent Inventor Names
John Andrew Altin
1
Mark S. Chee
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
11913952
1
Patent Primary Examiner
‌
Sahana S Kaup
1
CPC Code
‌
G01N 2333/70539
1
‌
C07K 7/08
1
Industry
Request Data

Find more entities like US Patent 11913952 Methods for detecting peptide/MHC/TCR binding

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.